|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
11677167 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
170527s2017 ts ob 001 0 eng d |
| 005 |
20240509213239.4 |
| 019 |
|
|
|a 988046733
|
| 020 |
|
|
|a 9781681084657
|q (electronic bk.)
|
| 020 |
|
|
|a 1681084651
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)988175263
|z (OCoLC)988046733
|
| 035 |
|
9 |
|a (OCLCCM-CC)988175263
|
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d MERUC
|d YDX
|d OCLCQ
|d N$T
|d AGLDB
|d IGB
|d OCLCF
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d OCLCQ
|d G3B
|d S8I
|d S8J
|d STF
|d D6H
|d OCLCQ
|
| 049 |
|
|
|a MAIN
|
| 050 |
|
4 |
|a RC848.F3
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 245 |
0 |
0 |
|a Nonalcoholic fatty liver disease (NAFLD) /
|c edited by Tatjana Ábel & Gabriella Lengyel.
|
| 260 |
|
|
|a Shāriqah (United Arab Emirates) :
|b Bentham Science Publishers,
|c 2017.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 520 |
|
|
|a Non-alcoholic fatty liver disease (NAFLD) is a common cause of elevated liver enzymes and chronic liver disease in Western countries. NAFLD is characterized by elevated liver enzymes in the absence of alcohol consumption and secondary causes of liver disease. It is an independent predictor of future risk of cardiovascular diseases, type 2 diabetes and metabolic syndrome (hypertension, abdominal obesity, dyslipidemia, glucose intolerance). This book is a quick reference guide for medical students and professionals about NAFLD. Readers will find a summary of epidemiology, clinical features, diagnosis, imaging techniques, histopathology, and disease management. The book also presents information about NAFLD linked with hepatocellular carcinoma and guidelines for treating NAFLD in pediatric patients. Each chapter presents information in a simple, structured manner making this text an ideal handbook for supplementing hepatology modules in medical curricula.
|
| 588 |
0 |
|
|a Print version record.
|
| 650 |
|
0 |
|a Fatty liver.
|0 http://id.loc.gov/authorities/subjects/sh85047473
|
| 650 |
|
0 |
|a Liver
|x Diseases.
|0 http://id.loc.gov/authorities/subjects/sh85077755
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Fatty liver.
|2 fast
|0 (OCoLC)fst00921974
|
| 650 |
|
7 |
|a Liver
|x Diseases.
|2 fast
|0 (OCoLC)fst01000640
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Ábel, Tatjana,
|e editor.
|
| 700 |
1 |
|
|a Lengyel, Gabriella,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|a Ábel, Tatjana.
|t Nonalcoholic Fatty Liver Disease (NAFLD).
|d Sharjah : Bentham Science Publishers, ©2017
|z 9781681084602
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|i 6beaf328-8f13-564f-94a0-2a6bd811de99
|s fe189caf-36c4-5b90-91f2-3c5259b87ab7
|
| 928 |
|
|
|t Library of Congress classification
|a RC848.F3
|l Online
|c UC-FullText
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1527021
|z eBooks on EBSCOhost
|g ebooks
|i 12453205
|
